INTRODUCTION
The T-lymphocyte cell surface glycoprotein cluster determinant 4 (CD4) has been studied extensively because it is the major receptor for HIV (1) . Repeated or persistent exposure of the immune system to viral antigen leads to general impairment of functional capability of immune competent cells, immune system dysfunction and an abnormal programme of cell death (2) . Consequently, there is progressive reduction in the number of CD4+ lymphocytes in HIV-infected individuals.
Although the CD4+ lymphocyte count provides important prognostic information, determination of lymphocyte subsets requires resources and technical expertise not routinely available in most developing countries. This is particularly true in most sub-Saharan African countries where approximately 67% of the world's HIV-infected population reside (3) . In these countries, affordable alternative markers of immunosuppression in HIV-infected patients would be valuable. Such markers would improve the ability of health care workers to monitor disease progression and help in clinical staging of HIV disease. Total lymphocyte count has been found to be highly correlated with CD4+ lymphocyte count (4) , and has been shown to be a prognostic indicator of both short-term and long-term survival (5, 6) . As a result, the WHO advocates the use of total lymphocyte count as an alternative to CD4+ lymphocyte count when the latter is not available (7) . Other simple blood indices, such as low red blood cell count, low haematocrit or haemoglobin, and elevated erythrocyte sedimentation rate (ESR) have been identified to be predictors of decreasing CD4+ lymphocyte counts (8) (9) (10) (11) .
Other studies have evaluated the role of potential cofactors for progression to AIDS or AIDS-related complex among HIV-infected persons. These factors include sociodemographic characteristics such as age (11) , cigarette smoking (12, 13) , and dietary intake of key nutrients (14) (15) (16) . The majority of these studies were conducted in developed countries and may not be generalisable to developing countries. Hence, there is a critical need for data from less developed countries, such as Tanzania, where more than 1.5 million people are estimated to have been infected by the HIV (17) . Furthermore, there is limited data to show the association between potential co-factors and CD4+ lymphocyte count among pregnant women. Thus, we studied predictors of CD4+ Iymphocyte count among HIV-seropositive and HIV-seronegative pregnant women in Dar es Salaam Tanzania, and assessed the association between CD4+ lymphocyte count and clinical stages of HIV/AIDS disease. We also examined samples from comparable HlV-seronegative women to describe the distribution of T-lymphocyte subsets among healthy pregnant women in the study population.
MATERIALS AND METHODS
Recruitment and study procedures: Data used in this report were collected from HIV-seronegative pregnant women receiving antenatal care in Dar es Salaam, Tanzania. HIV-seropositive women were participating in an ongoing randomised, controlled, double-blind clinical trial designed to assess the effect of supplementation of vitamins on perinatal transmission of HIV and progression of HIV disease. HIV-seronegative women were participating, as controls, in a sub-study aimed at assessing the psycho-social impact of HIV-seropositivity among women enrolled in the trial. Recruitment of HIV-seropositive women was done between April 1995 and March 1997 at four main antenatal clinics serving the three administrative districts of Dar es Salaam city. During the study period, all pregnant women between 12-27 weeks of gestation receiving antenatal care at selected clinics received a brief description of the study procedures and HIV pre-test counseling. Blood for HIV testing was collected from women who gave verbal consent (n=13,867). All women were requested to return to the clinics within one to two weeks for HIV post-test counselling. Out of 1,802 women who were HIV-seropositive, 1,085 (60%) returned for their results and consented to participate in the trial. Two hundred and eighty HIV-seronegative women were sampled from women who returned for HIV results at one of the clinics (Mwananyamala) and consented to be followed in the psycho-social sub-study.
After enrollment, all HIV-seropositive women were transferred to the study clinic at Muhimbili Medical Centre (MMC) where they were randomised and followed up to the time of delivery and for at least two years thereafter. Similar follow up was done among HlV-seronegative women at the Mwananyamala clinic. Standard antenatal and postnatal care and counseling were provided during the follow up period. At baseline, all women were interviewed by trained female nurses using standardised questionnaires to obtain information about sociodemographic characteristics, complete birth histories, sexual practices, and contraceptive use histories.
After interview, blood was collected in EDTA vacutainer tubes and transported to the laboratory within three to four hours for determination of T-lymphocyte subsets. Among HIVseropositive women, other haematological indices were estimated from the blood samples. To assess within-person variability of CD4+ lymphocyte measurements, we collected duplicate blood samples from 79 women. To ensure that technicians who conducted the tests could not identify which samples were from the same woman, the second sample of blood from each woman was labeled using a different serial number and presented to the laboratory with other samples. (18) . The FACScount system (Becton Dickinson Systems San Jose, CA) was used for enumeration of the Tlymphocyte subsets. Unlysed whole blood was mixed, reverse pipetted and run on the FACScount instrument and analysed according to the manufacturer's recommendation to obtain absolute counts of CD3+, CD4+ and CD8+ lymphocytes. Blood samples rejected by the FACScount system were analysed by using the FACScan cytometer (Becton Dickinson Immunocytometry Systems, San Jose, CA). The percentages of CD3+, CD4+ and CD8+ lymphocytes obtained from flow cytometry were multiplied by total Iymphocyte count measured on whole blood within six hours of collection on a Microdiff 18 Coulter cell counter (Coulter Corporation, Miami, FL) to obtain absolute counts of CD3+, CD4+ and CD8+ lymphocytes. Both FACScount and FACScan were serviced regularly by the manufacturers.
Estimation of haemoglobin and total white blood cells (WBC) was done by using the CBC5 Coulter counter (Coulter Corporation, Miami, FL) while WBC differential count was done manually. ESR was estimated by mixing 750 microlitres of blood with 250 microlitres of 3.8% disodium citrate in the ESR tube. The tube was left to stand upright at 90° for one hour and the results reported in mm/hour. For haematocrit, capillary tubes loaded with blood were sealed at one end with wax and centrifuged in a haematocrit centrifuge at 5000 rpm for 15 minutes. Later, packed cell volume was read on a hematocrit scale and reported as percentages. Vitamin A and E serum levels were determined by using high performance liquid chromatography procedures.
Statistical methods: These analyses included the 1029/ 1085 (94.8%) HIV-seropositive women and 280 HIVseronegative women with baseline CD4+ lymphocyte measurements. Two HIV-seropositive women with CD4+ lymphocyte count > 1700 cells/mm 3 were excluded from the analyses. All analyses were performed using SAS statistical software (SAS Institute Inc., Cary, NC, USA). The frequency distributions of CD4+ lymphocyte count and of all potential predictors was initially inspected and extreme data values checked. The maximum likelihood estimates of between-and withinperson variances in the underlying CD4+ lymphocyte count were obtained from a random effects model as implemented by SAS PROC MIXED (19) . The intraclass correlation coefficient (ICC) of reliability was obtained by dividing the between-person variance by the sum of the between-and within-person variances. The 95% confidence intervals for the ICC was calculated as given by Hankinson et al (20) . The coefficient of variation of CD4+ lymphocyte count is the ratio of the within-person standard deviation of the loge CD4+ lymphocyte count, to the sample mean loge CD4+ lymphocyte count.
The distribution of continuous variables among HIVseropositive and HIV-seronegative women was compared by using the Wilcoxon rank-sum test (21) . Age-adjusted Spearman's partial correlation coefficients (r s ) were used to quantify the associations between pairs of continuous variables. Later, multiple linear regression models were fitted to determine haematological indices which were significant predictors of CD4+ lymphocyte count among HIV-seropositive women. After identifying the final model, the distribution of the residuals was inspected and tested for normality. Since residuals from all models were not normal, robust variance estimates were used in all the results presented. This method gives standard errors for the regression coefficients that are asymptotically unbiased even if the normality assumption is violated (19) .
Further analyses were done to determine the ability of haematological indices in the final model to predict CD4+ count. Initially, predicted CD4+ lymphocyte count for each subject was calculated from the final regression model equation obtained when the index subject was excluded from the dataset. To assess the validity of the regression model for predicting CD4+ lymphocyte count in future patients, a jacknifed correlation between the observed and predicted CD4+ counts was calculated (22) . Later, CD4+ count was categorised into two groups (<200 cells/mm 3 and > 200 cells/mm 3 ) and we tested the ability of logistic regression models to identify women with CD4+ counts < 200 cells/mm 3 . Using probabilities of CD4+ count < 200 cells/mm 3 predicted by the models, we calculated the sensitivity and specificity of predicting CD4+ count < 200 cells/mm 3 at various cut-off points of predicted probabilities. The receiver operating characteristic (ROC) curve was used to determine the cut-off point which maximises both sensitivity and specificity (23) , and the area under the ROC curve was used to calculate the accuracy of the models.
RESULTS
The distribution of baseline socio-demographic characteristics, HIV clinical stages, haematological indices and serum nutrients in the study population are presented in Table 1 The CD4+ lymphocyte count reliability coefficient was 0.77 (95% confidence interval (CI) = 0.67-0.85) and the coefficient of variation (CV) was 24% (95% CI = 20-29%). Table 2 shows age-adjusted correlations between CD4+ lymphocyte count and continuous predictors among HIV-seropositive and HIV-seronegative women. Of all socio-demographic and anthropometric variables presented, age had the strongest correlation with CD4+ lymphocyte count among HIV-seropositive women (r s = -0.20, p = 0.0001). Mid-upper arm circumference had a weak but significant positive correlation with CD4+ lymphocyte count among HIV-seropositive women (r s = 0.08, p = 0.01). Among HIV-seronegative women, none of the socio-demographic and anthropometric variables were significantly associated with CD4+ lymphocyte count. All other T-lymphocyte subsets and haematological indices measured in this study were significantly correlated with CD4+ lymphocyte count among HIV-seropositive women. The strongest association was observed between CD4+ lymphocyte count with CD3+ (r s = 0.66, p = 0.0001), CD8+ (r s = 0.28, p = 0.0001) lymphocyte counts, and total white blood cell count (r s = 0.22, p = 0.0001). Similarly, CD3+ (r s = 0.87, p =0.0001) and CD8+ (r s = 0.53, p = 0.0001) lymphocyte count were significantly correlated with CD4+ lymphocyte count among HIV-seronegative women. Baseline serum vitamins A and E were not correlated with CD4+ lymphocyte count among HIVseropositive women.
Results from multiple linear regression models are presented in Table 3 . As shown in Model 1, total WBC and ESR were the only haematological indices that were significantly correlated with CD4+ lymphocyte count in were significantly correlated with CD4+ lymphocyte count in multivariate analyses.
The sensitivity and specificity of predicting CD4+ lymphocyte count below 200 cells/mm 3 using model probabilities at various cut-off points was calculated by using the ROC curve. The proportion of the area of the entire graph that lies beneath the curve was 0.63. The sensitivity and specificity was maximised when the models predicted probabilities was greater than 0.127. If all patients with this predicted probabilities were classified as having CD4+ lymphocyte counts below 200 cells/mm 3 , the sensitivity and specificity of this procedure was 60% and 64% respectively. Increasing the probability cut-off point was associated with increasing sensitivity and decreasing specificity.
DISCUSSION
The reliability of CD4+ lymphocyte measurements was high indicating that laboratory error was not a major source of misclassification in this study. The distribution of T-lymphocyte subsets among healthy HlV-seronegative pregnant women were similar to those reported by other studies in both developing and industrialised countries (mean 736 -828 cells/mm 3 ) (24) (25) (26) . Several studies have observed a reduction in CD4+ lymphocyte count during pregnancy among HIV-seropositive women (24) (25) (26) (27) and a return to normal levels at time of delivery (25, 27) or during the first few weeks after delivery (24, 26) . Potential mechanisms to explain these changes include pregnancy induced leukocytosis that leads to increased WBC count and decreased percentage of lymphocytes(28), haemodilution resulting from increased blood volume (24) , re-distribution of CD4+ cells in tissues and lymph nodes (27) , and hormonal changes associated with pregnancy (29) . These changes complicate the interpretation of T-lymphocyte subset results in studies involving pregnant women. The findings of this study provide information about the distribution of T-lymphocyte subsets among both HIV-seropositive and HIVseronegative pregnant women. The results from healthy HIV-seronegative women provide an important source of information which can be used as reference values for pregnant women in Tanzania.
Most HIV-seropositive women in this study were asymptomatic in the WHO clinical stage 1. The distribution of T-lymphocyte subsets observed in this population was comparable to those reported in other studies involving asymptomatic HIV-seropositive pregnant women (26) . CD4+ lymphocyte count of less than 200 cells/mm 3 is considered by the Centers for Diseases Control and Prevention (CDC) as an AIDS-defining laboratory criterion(30). Although a substantial proportion of HIVseropositive women in this study(12.8%) met this laboratory criterion, most of these women were healthy and had no symptoms suggestive of AIDS. This suggests that laboratory parameters alone may not be adequate to define clinical stages of HIV disease among pregnant women in this population.
Although CD4+ lymphocyte count is the most used index of the level of cell mediated immunity in HIVinfected patients, it is not readily available in most developing countries. As a result, numerous simple and less expensive hematological indices are being considered as alternative measures of immunosuppression in HIVinfected people. For example, the cost of full blood count is about 21% of that of CD4+ lymphocyte count (4) . Several studies have reported on the association between CD4+ lymphocyte count and other simple haematological indices (4, 5, 8, 9, 10) . Most of these studies have reported poor correlations in asymptomatic patients and much stronger associations in patients with advanced disease (4) . In this study, we observed weak but significant correlations between haematological indices and CD4+ lymphocyte count in univariate analyses. In multivariate analyses, only total WBC count and ESR remained significant predictors of CD4+ lymphocyte count. However, WBC and ESR explained a very small proportion of the variance of CD4+ lymphocyte measurements, and had unacceptably low sensitivity and specificity even when the dichotomous cut-off point was optimised using an ROC curve. Hence, these simple haematological indices cannot be recommended for use as markers of cell mediated immunosuppression among asymptomatic women.
Women's age and mid-upper arm circumference (MUAC) were significant predictors of CD4+ lymphocyte count. The role of age as a predictor of CD4+ lymphocyte count among adults is uncertain. In normal healthy adults, an increase in CD4+ lymphocyte count with age has been reported by some studies (31, 32) , while other studies have not observed any association (31) . Similar conflicting results have been reported among HIV-seropositive populations (33) . In this study, CD4+ lymphocyte count was inversely correlated with age among HIV-seropositive women. We also observed a weak but significant positive correlation between CD4+ lymphocyte count and MUAC. These associations might be confounded by duration of HIV-infection. Relatively high CD4+ lymphocyte count among younger women, with presumably more recent seroconversion, might be due to shorter duration of HIVinfection. Duration of infection has been shown to be a major predictor of CD4+ lymphocyte count and disease progression among HIV infected adults (34) . Among HIVseronegative women, CD4+ lymphocyte count was not significantly correlated with age and anthropometric variables. This suggests that the observed associations between age and MUAC among HIV-seropositive women are related to HIV disease.
This study has several limitations. First, the power of this study to assess predictors of clinical stages of HIV disease was limited because most women were asymptomatic in WHO clinical stage 1. Secondly, lack of information about the duration of infection limits our ability to adjust for this important predictor of CD4+ lymphocyte count in the analyses presented in this report. Hence, the observed association between CD4+ lymphocyte count and predictors might be confounded by duration of HIV disease. Thirdly, physiological changes associated with pregnancy were likely to have influenced the distribution of CD4+ lymphocyte count in this study. These changes might have affected some of the associations between potential predictors and CD4+ lymphocyte count.
In conclusion, HIV-seronegative women had significantly higher CD4+ lymphocytes count than HIVseropositive women. Most HIV-seropositive women were asymptomatic in WHO clinical stage 1, but CD4+ counts were lower among women with stage 2 and 3 disease. Women's age and MUAC were significantly associated with CD4+ lymphocyte count among HIV-seropositive women. Results from simple haematological tests were weakly correlated with CD4+ lymphocyte count in both univariate and multivariate analysed. Hence, there were no simple haematological tests which could be recommended as alternative measures of HIV-related immunosuppression in this population of mainly asymptomatic women.
